Investing

Clairity, Myriad Genetics, MagView partner on breast cancer risk tools

BOSTON/SALT LAKE CITY/FULTON - Clairity, Myriad Genetics, Inc. (NASDAQ:MYGN), and MagView announced Tuesday a collaboration aimed at improving breast cancer risk assessment by integrating their ...
manilatimes

Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health

For the first time, clinicians and patients will have access to an integrated view of genotype (Myriad’s MyRisk with RiskScore test) and phenotype (Clairity Breast) through MagView’s Luminary Risk ...
The Business Journals

MagView moving 75 workers from Montgomery to Howard County

MagView has inked a 15,000-square-foot lease with St. John Properties to move its headquarters to Maple Lawn. Medical software company MagView is relocating its 75-worker headquarters to Maple Lawn ...
Finanznachrichten

Myriad Genetics, Inc.: Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health

BOSTON and SALT LAKE CITY and FULTON, Md., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Clairity, Myriad Genetics, Inc. (NASDAQ: MYGN), and MagView, today announced a joint collaboration in an effort to identify ...